Executive readout · one minute
Call research workspace
Read the call alongside every captured source. Audio, transcript, slides and SEC filings stay in one workspace.
VRCA
$4.97
+2.26%
VRCA · Verrica Pharmaceuticals Inc.
$4.97
+0.11 (+2.26%)
At close · Aug 14
Going-concern doubt
— flagged Aug 6, 2026
Substantial doubt about the company's ability to continue as a going concern.
“the Company has concluded that substantial doubt exists regarding its ability to continue as a going concern within one year after the date these consolidated financial statements are issued.”View the 10-Q filed Aug 6, 2026
Market Cap
$87.44M
Shares
17.18M
All earnings calls
Earnings call · FY2025 Q4
Verrica Pharmaceuticals Inc. Q4 FY2025 Earnings Call
Verrica Pharmaceuticals Inc. Q4 FY2025 Earnings Call
Research coverage
2 live sources
Switch sources without leaving this page or losing your listening position.
Revenue · derived Q4
$5.09M
+1380.2% YoY
Net income · derived Q4
-$8.07M
Research materials
Open the source you need; every reader stays inside this workspace.
SEC filing · Item 2.02
8-K earnings release
Filed Mar 11, 2026 · complete as-filed document
SEC periodic report
10-K report
Filed Mar 11, 2026 · complete as-filed document